Adaptive Biotechnologies (ADPT) Gross Profit Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 40.58% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 1.18% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -0.65% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 10.00% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 2.33% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 2.62% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 42.33% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 3.25% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 0.56% |
| 10 | Adaptive Biotechnologies | 2.66 Bn | 2.45 Bn | 52.17 Mn | 40.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.11% |
| Dec 31, 2025 | 19.30% |
| Sep 30, 2025 | 42.29% |
| Jun 30, 2025 | 10.33% |
| Mar 31, 2025 | 41.46% |
| Dec 31, 2024 | 46.52% |
| Sep 30, 2024 | 21.26% |
| Jun 30, 2024 | 14.38% |
| Mar 31, 2024 | 10.12% |
| Dec 31, 2023 | 46.91% |
| Sep 30, 2023 | -2.83% |
| Jun 30, 2023 | -64.23% |
| Mar 31, 2023 | 6.80% |
| Dec 31, 2022 | 39.61% |
| Sep 30, 2022 | 15.77% |
| Jun 30, 2022 | 22.88% |
| Mar 31, 2022 | 17.72% |
| Dec 31, 2021 | -57.35% |
| Sep 30, 2021 | 7.07% |
| Jun 30, 2021 | 32.83% |